Comparison between Anthem Biosciences IPO and Gem Aromatics IPO.
Anthem Biosciences IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Gem Aromatics IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Anthem Biosciences IPO is up to ₹3,395.00 Cr whereas the issue size of the Gem Aromatics IPO is up to ₹451.25 Cr. The final issue price of Anthem Biosciences IPO is ₹570.00 per share and of Gem Aromatics IPO is ₹325.00 per share.
| Anthem Biosciences IPO | Gem Aromatics IPO | |
|---|---|---|
| Face Value | ₹2 per share | ₹2 per share |
| Issue Price (Lower) | ₹540.00 per share | ₹309.00 per share |
| Issue Price (Upper) | ₹570.00 per share | ₹325.00 per share |
| Issue Price (Final) | ₹570.00 per share | ₹325.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹50.00 per share | |
| Market Lot Size | 26 shares | 46 shares |
| Fresh Issue Size | 0 shares | 53,84,615 shares |
| Fresh Issue Size (Amount) | up to ₹0.00 Cr | up to ₹175.00 Cr |
| OFS Issue Size | 5,95,75,319 shares | 85,00,000 shares |
| OFS Issue Size (Amount) | up to ₹3,395.00 Cr | up to ₹276.25 Cr |
| Issue Size Total | 5,95,75,319 shares | 1,38,84,615 shares |
| Issue Size Total (Amount) | up to ₹3,395.00 Cr | up to ₹451.25 Cr |
Anthem Biosciences IPO opens on Jul 14, 2025, while Gem Aromatics IPO opens on Aug 19, 2025. The closing date of Anthem Biosciences IPO and Gem Aromatics IPO is Jul 16, 2025, and Aug 21, 2025, respectively.
| Anthem Biosciences IPO | Gem Aromatics IPO | |
|---|---|---|
| Anchor Bid Date | Jul 11, 2025 | Aug 18, 2025 |
| Issue Open | Jul 14, 2025 | Aug 19, 2025 |
| Issue Close | Jul 16, 2025 | Aug 21, 2025 |
| Basis Of Allotment (Tentative) | Jul 17, 2025 | Aug 22, 2025 |
| Initiation of Refunds (Tentative) | Jul 18, 2025 | Aug 25, 2025 |
| Credit of Share (Tentative) | Jul 18, 2025 | Aug 25, 2025 |
| Listing date (Tentative) | Jul 21, 2025 | Aug 26, 2025 |
| Anchor Lockin End date 1 | Aug 15, 2025 | Sep 20, 2025 |
| Anchor Lockin End date 2 | Oct 14, 2025 | Nov 19, 2025 |
Anthem Biosciences IPO P/E ratio is 70.62, as compared to Gem Aromatics IPO P/E ratio of 28.52.
| Anthem Biosciences IPO | Gem Aromatics IPO | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated)Anthem Biosciences Ltd.'s revenue increased by 30% and profit after tax (PAT) rose by 23% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Gem Aromatics Ltd.'s revenue increased by 11% and profit after tax (PAT) rose by 7% between the financial year ending with March 31, 2025 and March 31, 2024.
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 76.87 | 75 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 74.68 | 55.06 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 70.62 | 28.52 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹31867.39 Cr. | ₹1697.71 Cr. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 20.82% | 18.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.88% | 16.02% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.05 | 0.78 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.07 | ₹11.39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 20.82% | 18.80% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Anthem Biosciences IPO Retail Individual Investors (RII) are offered 2,07,95,834 shares while in Gem Aromatics IPO retail investors are offered 2,07,95,834 shares. Qualified Institutional Buyers (QIB) are offered 1,18,83,333 shares in Anthem Biosciences IPO and 27,76,923 shares in Gem Aromatics IPO.
| Anthem Biosciences IPO | Gem Aromatics IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,78,24,999 shares | 41,65,383 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 1,18,83,333 shares | 27,76,923 shares |
| NII | 89,12,500 shares | 20,82,693 shares |
| RII | 2,07,95,834 shares | 48,59,616 shares |
| Employee | 1,58,653 shares | 0 shares |
| Others | ||
| Total | 5,95,75,319 shares | 1,38,84,615 shares |
Anthem Biosciences IPO subscribed 67.42x in total, whereas Gem Aromatics IPO subscribed 30.45x.
| Anthem Biosciences IPO | Gem Aromatics IPO | |
|---|---|---|
| QIB (times) | 192.80x | 53.76x |
| NII (times) | 44.70x | 45.96x |
| Big NII (times) | 51.66x | 48.48x |
| Small NII (times) | 30.80x | 40.91x |
| RII (times) | 5.98x | 10.49x |
| Employee (times) | 6.99x | |
| Other (times) | ||
| Total (times) | 67.42x | 30.45x |
